Article Type
Article
Changed
Tue, 12/13/2016 - 12:08
Display Headline
Stack-on UFH Can Lead to Overanticoagulation

Article PDF
026090011.pdf
Author and Disclosure Information

Issue
Federal Practitioner - 26(9)
Publications
Federal Practitioner
Page Number
11
Legacy Keywords
stack-on, unfractionated heparin, UFH, anticoagulation, overanticoagulation, enoxaparin, endogenous thrombin potential, ETP, activated clotting time, ACT, anti-Xa, anti-IIa, blood disordersstack-on, unfractionated heparin, UFH, anticoagulation, overanticoagulation, enoxaparin, endogenous thrombin potential, ETP, activated clotting time, ACT, anti-Xa, anti-IIa, blood disorders
Sections
Pharmacology
Author and Disclosure Information

Author and Disclosure Information

Article PDF
026090011.pdf
Article PDF
026090011.pdf

Issue
Federal Practitioner - 26(9)
Issue
Federal Practitioner - 26(9)
Page Number
11
Page Number
11
Publications
Federal Practitioner
Publications
Federal Practitioner
Article Type
Article
Display Headline
Stack-on UFH Can Lead to Overanticoagulation
Display Headline
Stack-on UFH Can Lead to Overanticoagulation
Legacy Keywords
stack-on, unfractionated heparin, UFH, anticoagulation, overanticoagulation, enoxaparin, endogenous thrombin potential, ETP, activated clotting time, ACT, anti-Xa, anti-IIa, blood disordersstack-on, unfractionated heparin, UFH, anticoagulation, overanticoagulation, enoxaparin, endogenous thrombin potential, ETP, activated clotting time, ACT, anti-Xa, anti-IIa, blood disorders
Legacy Keywords
stack-on, unfractionated heparin, UFH, anticoagulation, overanticoagulation, enoxaparin, endogenous thrombin potential, ETP, activated clotting time, ACT, anti-Xa, anti-IIa, blood disordersstack-on, unfractionated heparin, UFH, anticoagulation, overanticoagulation, enoxaparin, endogenous thrombin potential, ETP, activated clotting time, ACT, anti-Xa, anti-IIa, blood disorders
Sections
Pharmacology
Article Source

PURLs Copyright

Inside the Article

Article PDF Media